OmicsChart

AI in biopharma only delivers value when data, analysis, and decisions are tightly connected

Martinsried, Germany · Founded 2023 · $20K raised

Headquarters
Martinsried
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$20K
Last Round
$20K SeedJun 2023
Rounds
1

About

OmicsChart (now rebranded as Vedaly) is a patient-centric cancer data and analytics platform for translational cancer biologists and biopharma R&D teams. The platform enables translational and R&D teams to architect scalable data foundations, integrate complex biological and clinical data, and operationalize AI so it directly informs scientific and strategic decisions. OmicsChart joined the Milner Therapeutics Institute network at Cambridge University in 2024 and rebranded to Vedaly in November 2025 to reflect its expanded scope of services.

Summary

OmicsChart is an Artificial Intelligence company based in Martinsried, Germany, founded in 2023. It has raised $20K in total across 1 round, most recently a $20K Seed round in Jun 2023. Investors include Techstars, PharmStars and Debiopharm Innovation.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJun 2023
$20K

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OmicsChart on Indexed.vc
<a href="https://indexed.vc/companies/omicschart"><img src="https://indexed.vc/api/badge/company/omicschart" alt="OmicsChart on Indexed.vc" width="260" height="76" /></a>